Get the right headache diagnosis before any procedure
Stem cell therapy for migraines in Istanbul, Turkey
Our Istanbul team confirms your headache type first, then matches you to the acute and preventive care that actually reduces attacks.
Condition-specific editorial anatomy. Explanatory labels remain in accessible text.
Evidence position
What is known, what is investigational, and what is not demonstrated
Diagnosis-first headache care
Migraine, tension-type headache, cluster headache, and medication-overuse headache each get a different pathway from us.
We won't sell an intranasal shortcut
CGRP-targeted medicines, triptans, gepants, and onabotulinumtoxinA for eligible chronic migraine are proven options we help you access.
We keep procedures straight
Results vary between patients and stem cell therapy is not a guaranteed cure — we won't sell you an unproven cell procedure for headache prevention.
Direct answer
What the current evidence says
We don't offer stem cells or exosomes as a migraine cure, because no cell-based route has proven it prevents attacks. What we do offer is a thorough headache work-up that rules out secondary causes, addresses medication overuse, and connects you with proven acute and preventive options — CGRP therapies, triptans, gepants, and more. Request your free medical evaluation and our physicians will map the right plan to your exact headache pattern.
Clinical map
Start with the diagnosis, stage, and treatment context
We build every plan around an accurate headache diagnosis and evidence-based acute and preventive treatment.
Established care comes first
- Acute treatment: We help personalize analgesics, triptans, gepants, antiemetics, or other guideline options for your attacks.
- Prevention: We match oral preventives, CGRP therapies, onabotulinumtoxinA, and lifestyle support to your frequency and history.
- Headache diary: We track headache days, migraine days, medication use, and disability before and after any treatment change.
- 01
Migraine phenotype
We record aura, attack duration, associated symptoms, disability, triggers, and how you respond to acute medication.
- 02
Chronicity and overuse
Headache days and medication days help us distinguish episodic, chronic, and overuse patterns.
- 03
Red flags
Thunderclap onset, fever, pregnancy, new neurologic deficit, or a major pattern change gets urgent assessment first.
Evidence ledger
Read the actual study, including the result that did not change
Each row keeps product identity, route, endpoint, and limitation together so one trial cannot become a generic treatment claim.
01 American Headache Society migraine prevention position statement
Open source- Product
- CGRP-targeting preventive therapies, not a cell product
- Route
- Treatment-specific established routes
- Design
- Evidence review and expert position statement
- Finding
- CGRP-targeting therapies are supported as a first-line migraine prevention option without requiring failure of older preventive classes.
- Limitation
- The statement does not establish a stem-cell or exosome treatment or any intranasal regenerative route.
Product and route
A mechanism is not a clinical outcome
- 01
We won't sell an intranasal shortcut
A delivery concept needs real human pharmacology and clinical endpoint data before we'd ever recommend it.
BoundaryEvidence applies only to the studied product, population, dose, route, comparator, and endpoint.
- 02
We keep procedures straight
Nerve blocks, onabotulinumtoxinA, PRP, MSCs, and exosomes are different, and we explain which is actually appropriate for you.
BoundaryEvidence applies only to the studied product, population, dose, route, comparator, and endpoint.
Outcomes before travel
Decide what meaningful change would look like
A baseline and a time point matter more than an isolated testimonial. These measures should be chosen before any intervention.
- 01
Monthly migraine days
- 02
Monthly headache days
- 03
Acute-medication days
- 04
MIDAS or HIT-6 disability score
- 05
Any side effects or emergency visits
Specialist review
What a complete Istanbul review needs
Our Istanbul team confirms your headache type first, then matches you to the acute and preventive care that actually reduces attacks.
Records and baseline
- Headache diary covering at least four weeks
- Neurologic examination and prior imaging when indicated
- Current and previously tried acute and preventive medicines
- Medication-overuse, sleep, mood, hormonal, and cardiovascular review
- The exact plan, route, and monitoring we recommend for you
Safety and planning checks
- New red flags or a major pattern change get evaluated before elective travel.
- We keep your established prevention plan running unless your neurologist changes it.
- Your plan targets fewer migraine days and less disability — not vague claims about inflammation.
Transparent planning
Build the medical plan before the package
A quote should follow record review, product disclosure, route rationale, and a written follow-up plan. This page does not invent a universal price.
- New red flags or a major pattern change get evaluated before elective travel.
- We keep your established prevention plan running unless your neurologist changes it.
- Your plan targets fewer migraine days and less disability — not vague claims about inflammation.
Questions the plan must answer
- 01
We won't sell an intranasal shortcut: A delivery concept needs real human pharmacology and clinical endpoint data before we'd ever recommend it.
- 02
We keep procedures straight: Nerve blocks, onabotulinumtoxinA, PRP, MSCs, and exosomes are different, and we explain which is actually appropriate for you.
Primary reading
Guidelines, trials, and regulatory context
FAQ
Questions patients ask before an Istanbul review
Request Medical Evaluation
Begin a personalized treatment conversation with our medical team.
Share your case in confidence. Our international coordinators review every enquiry and respond within 24 hours, in your language.